The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Forecasted Market Value Of The Analgesics Market Across 2026–2030?
The analgesics market has seen consistent expansion in recent years. It is anticipated to increase from $113.1 billion in 2025 to $115.82 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 2.4%. The historical growth of this market can be attributed to a rise in global musculoskeletal disorders, an increase in surgical procedures, the growing incidence of cancer, the expansion of hospital infrastructure, and the widespread availability of generic analgesics.
The analgesics market is projected to experience consistent expansion over the upcoming years, with an anticipated growth to $132.6 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 3.4%. This projected growth can be attributed to advancements in personalized medicine, increased research and development efforts in opioid alternatives, the expansion of e-pharmacies and digital healthcare, a rising geriatric population, and the adoption of smart manufacturing processes within the pharmaceutical industry. Significant trends expected during this forecast period include the emergence of personalized pain management solutions, a rise in the development of both opioid and non-opioid drugs, the broadening of hospital and retail pharmacy channels, increased demand for chronic and cancer pain treatments, and a growing awareness regarding safe analgesic usage.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2438&type=smp
Which Market Drivers Are Supporting The Expansion Of The Analgesics Market?
The projected increase in healthcare spending is anticipated to drive the expansion of the analgesics market. Healthcare expenditures broadly include all costs linked to delivering health services, family planning activities, nutritional programs, and health-oriented emergency assistance. A rise in these expenditures encourages research and development within the pharmaceutical industry, focusing on novel and improved analgesic drugs. For instance, in May 2024, the Office for National Statistics, a UK-based government department, reported that total healthcare spending experienced a nominal increase of 5.6% from 2022 to 2023. Consequently, the rising healthcare expenditures are fueling the growth of the analgesics market.
What Segmentation Levels Are Considered In The Analgesics Market?
The analgesics market covered in this report is segmented –
1) By Type: Non-opioids, Opioids
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores
3) By Application: Internal Analgesics, External Analgesics
Subsegments:
1) By Non-Opioids: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Acetaminophen (Paracetamol), Salicylates
2) By Opioids: Natural Opioids, Semi-Synthetic Opioids, Synthetic Opioids
What Trends Are Projected To Affect The Analgesics Market?
Leading companies in the analgesic market are increasingly prioritizing the introduction of combination analgesics to secure a competitive advantage. Combination analgesics are drugs containing a mixture of two or more distinct pain-relieving (analgesic) substances. These formulations are typically designed to offer more effective pain management by addressing pain through multiple pathways. For example, in February 2024, Hikma Pharmaceuticals plc, a UK-based pharmaceutical firm, introduced COMBOGESIC IV (acetaminophen and ibuprofen) in the United States. COMBOGESIC IV is an intravenous preparation that combines acetaminophen (paracetamol) and ibuprofen, delivering dual-action pain relief by utilizing the analgesic and anti-inflammatory qualities of both medications. Developed as a new non-opioid choice for pain management, this intravenous formulation provides 1,000 mg of acetaminophen and 300 mg of ibuprofen, serving as an effective substitute amid increasing worries about opioid usage. COMBOGESIC IV offers over twice the pain relief of its individual ingredients, with a more rapid onset and a desirable safety profile.
Which Leading Firms Are Contributing To The Growth Of The Analgesics Market?
Major companies operating in the analgesics market are Pfizer Inc., Johnson & Johnson Services Inc., Medley Pharmaceuticals Limited, AbbVie Inc., Bayer HealthCare Pharmaceuticals LLC, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Co., AstraZeneca Plc., Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical company Limited, Eli Lilly and Company, Reckitt Benckiser Group plc, Viatris Inc., Teva Pharmaceuticals Industries Ltd., Sun Pharmaceutical Industries Limited, Purdue Pharma L.P, Cipla Limited, Allergan Inc., Endo International plc, Amneal Pharmaceuticals LLC, Mallinckrodt Pharmaceuticals Ltd., Chattem Inc., Hisamitsu Pharmaceutical Co.Inc., GW Pharmaceuticals, Verve Health Care Ltd., Alder BioPharmaceuticals Inc., Achelios Therapeutics Inc., WEX Pharmaceuticals Inc., Zynerba Pharmaceuticals, McNeil Consumer & Specialty Medical Products, Innovative Med Concepts LLC
Read the full analgesics market report here:
https://www.thebusinessresearchcompany.com/report/analgesics-global-market-report
How Is The Analgesics Market Distributed Across Key Geographic Regions?
North America was the largest region in the analgesics market in 2025. Middle East is expected to be the fastest-growing region in the global analgesics market during the forecast period. The regions covered in the analgesics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Analgesics Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=2438&type=smp
Browse Through More Reports Similar to the Global Analgesics Market 2026, By The Business Research Company
Analgesics Market Report 2026
https://www.thebusinessresearchcompany.com/report/analgesics-global-market-report
Pain Management Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/pain-management-drugs-global-market-report
Anesthetics Market Report 2026
https://www.thebusinessresearchcompany.com/report/anesthetics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model